Suppr超能文献

腹部放线菌病的临床特征:一项系统综述

Clinical aspects of abdominal actinomycosis: a systematic review.

作者信息

Manterola Carlos, Grande Luis, Riffo-Campos Ángela L, Salgado Carla, Otzen Tamara

机构信息

Department of Surgery, Universidad de La Frontera, Temuco, Chile.

Center of Excellence in Morphological and Surgical Studies (CEMyQ), Universidad de La Frontera, Temuco, Chile.

出版信息

ANZ J Surg. 2020 Jul;90(7-8):1465-1468. doi: 10.1111/ans.16141. Epub 2020 Jul 30.

Abstract

BACKGROUND

Abdominal actinomycosis (AA) is a rare infection. The aim of this study was to summarize the evidence available on AA.

METHODS

A systematic review was conducted. Data sources included Trip Database, BIREME, SciELO, Cochrane Library, WoS, MEDLINE, EMBASE, SCOPUS, IBECS and LILACS. Eligibility criteria included: studies related to surgically treated AA, in adult population, without language and sex restriction, published between 1966 and 2019. The following variables were analysed: publication year, age, sex, geographical origin, location of lesions, clinical manifestations, risk factors, species isolated and treatments used.

RESULTS

A total of 1505 studies were initially identified. After scrutinizing titles and abstracts, and checking duplications, 221 articles including 406 subjects with AA were included. All were case reports or series. Mean age of subjects was 49.2 years and 56.2% were female. The highest proportion of articles was published between 2015 and 2019 (18.7%). Publications were predominantly from the USA (12.2%). Structures usually involved were abdominal wall, colon and appendix. The most common presentation was abdominal mass (39.2%). In 42.1% of patients, an associated factor was found, highlighting intrauterine devices (14.3%). The microbiology studies highlighted Actinomyces israelli. Morbidity, recurrence and verified mortality were 18.2%, 1.0% and 2.2%, respectively. Penicillin was the most used antibiotic.

CONCLUSION

Evidence about AA is scarce and dispersed within a reduced range of articles and cases.

摘要

背景

腹部放线菌病(AA)是一种罕见的感染性疾病。本研究旨在总结关于AA的现有证据。

方法

进行了一项系统综述。数据来源包括Trip数据库、BIREME、SciELO、Cochrane图书馆、WoS、MEDLINE、EMBASE、SCOPUS、IBECS和LILACS。纳入标准包括:与手术治疗的AA相关的研究,成年人群,无语言和性别限制,发表于1966年至2019年之间。分析了以下变量:发表年份、年龄、性别、地理来源、病变部位、临床表现、危险因素、分离出的菌种和使用的治疗方法。

结果

最初共识别出1505项研究。在仔细审查标题和摘要并检查重复项后,纳入了221篇文章,其中包括406例AA患者。所有均为病例报告或病例系列。患者的平均年龄为49.2岁,56.2%为女性。文章发表比例最高的时间段为2015年至2019年(18.7%)。出版物主要来自美国(12.2%)。通常受累的结构是腹壁、结肠和阑尾。最常见的表现是腹部肿块(39.2%)。在42.1%的患者中发现了相关因素,突出显示了宫内节育器(14.3%)。微生物学研究突出显示了以色列放线菌。发病率、复发率和已证实的死亡率分别为18.2%、1.0%和2.2%。青霉素是最常用的抗生素。

结论

关于AA的证据稀少且分散在数量有限的文章和病例中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验